Zhejiang Huahai Pharmaceutical News and Activities

Zhejiang Huahai Pharmaceutical is one of the...

• CSI 500;
• TOB Iconic 10,000.

Zhejiang Huahai Pharmaceutical is a company listed under the stock ticker 600521 (CN).

View the org chart displaying its 18 main executives

Most searched biographies at Zhejiang Huahai Pharmaceutical

• Baohua Chen, General Manager and Director
• Hong Li, Chairman of the Board
• Weiguang Shan, Director

Create your alert
to follow the executive moves at Zhejiang Huahai Pharmaceutical.

Zhejiang Huahai Pharmaceutical has 1,918 competitors including Sanofi (France), Moderna (United States (USA)) and Eli Lilly (United States (USA)).

Popular M&A news in Pharmaceuticals

• Vertex Pharmaceuticals has announced the acquisition of Crinetics Pharmaceuticals  (posted on July 7 2026).
• Novartis has announced the acquisition of Myricx Bio  (posted on July 6 2026).
• Ipsen has announced the acquisition of Kartos Therapeutics  (posted on July 3 2026).

Popular contacts in Pharmaceuticals

• David Ricks - President, Chief Executive Officer and Chairman of the Board at Eli Lilly
• Joaquin Duato - Chief Executive Officer and Chairman of the Board at Johnson & Johnson
• Richard Saynor - Chief Executive Officer at Sandoz

Learn more about the Pharmaceuticals industry

Press releases by Zhejiang Huahai Pharmaceutical

Social media about Zhejiang Huahai Pharmaceutical

• Zhejiang Huahai Pharmaceutical on Wikipedia, Google News & Yahoo Finance
• Zhejiang Huahai Pharmaceutical on LinkedIn, X (Twitter) & YouTube